Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

Healthcare providers have called on the government to ensure that there is proper education of Nigerian citizens about asthma and Chronic Obstructive Pulmonary Disease (COPD), as well as improved ...

AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...

Shortness of breath, chronic coughing, or wheezing should not be ignored as they can be signs of a pulmonary condition. A ...

A recent study published in CHEST found that treatment-naïve adults with obesity-hypoventilation syndrome receiving a combination of acetazolamide and atomoxetine for 2 weeks had improved ...

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...

Patients with respiratory conditions, such as asthma and COPD, are being encouraged to use apps to manage their symptoms.

Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Biologics represent a breakthrough in the management of airway diseases, offering precision treatments that target specific immune pathways. This special issue, Biologics for Airway Diseases: From ...

Pulmonary embolism, or PE, is a serious and sometimes life-threatening condition that occurs when a blood clot travels to the ...